Skip to main content

Procept Biorobotics

PROCEPT BioRobotics Corp is a surgical robotics medical technology enterprise headquartered in San Jose, California. The company designs, develops, and commercializes advanced robotic systems for urological surgery and minimally invasive interventions. Its flagship product, the Aquabeam System, utilizes automated waterjet technology for targeted tissue ablation during benign prostatic hyperplasia treatments. Principal revenue is derived through capital sales of robotic surgical consoles, disposable handpiece accessories, and service maintenance contracts. The enterprise serves hospitals, surgical centers, and urology specialists. PROCEPT BioRobotics Corp is publicly listed on the Nasdaq Stock Market.

8 of the funds FundTelligence covers report a position in Procept Biorobotics.

Sector
Health Care
Country
United States
Funds holding it
8
Exposure themes
Healthcare, Robotics & Automation, Surgical Robotics

Funds holding Procept Biorobotics

Loading...